Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Esophageal Squamous Cell Carcinoma 5 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Rectal Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Testicular Neoplasms 1 Surgery 1 Stress, Psychological 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solitary Fibrous Tumor, Pleural 1 Seminoma 1 Recurrence 1 Postoperative Complications 1

Interventions

Doxorubicin 7 pembrolizumab 5 Radiotherapy 5 Specimen Handling 4 Radiation 4 Magnetic Resonance Spectroscopy 4 palbociclib 3 eribulin 3 Ifosfamide 3 Biopsy 3 pazopanib 2 brigimadlin 2 abemaciclib 2 Immunoglobulin G 2 zimberelimab 1 toripalimab 1 talimogene laherparepvec 1 silmitasertib 1 selinexor 1 ribociclib 1 peposertib 1 pemigatinib 1 olaratumab 1 olaparib 1 mirdametinib 1 liposomal doxorubicin 1 lenvatinib 1 enzalutamide 1 durvalumab 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Neoadjuvant Therapy × 1 year × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡